Human Longevity

Sun Genomics is a precision nutrition company focused on curing dysbiosis through the gut microflora and personalized solutions. Its flagship product Floré, is a microbiome test and custom synbiotics solution that utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product based on their unique gut profiles. The company also offers: Floré Tots, Kids, and Baby, available for kids up to age 0-12, and comes in an easy digestive powder to mix with their favorite drink. Floré Clinical, which is specifically for professional practitioners and their patients. Floré Defense, Balance, and Performance for sports teams and athletes.

Solius is a company that manufactures a light therapy kiosk designed to stimulate the body's natural production of vitamin D through the use of specific wavelengths of ultraviolet B (UVB) light. Founded in 2011 and based in Bainbridge Island, Washington, Solius aims to address vitamin D deficiency by providing the benefits of sunlight without the harmful effects of UVA rays or the drawbacks associated with dietary supplements. The device enhances physical, mental, and immune function by promoting the production of essential hormones and peptides critical to overall health. Additionally, Solius has developed an ultraviolet light system intended for treating COVID-19. The company's focus on user experience and safety positions it as a pioneer in the medical device sector.

DoctorsForMe.AI helps patients with complex conditions find the doctors that they need the most. When you or your family is diagnosed with a cancer or other complex condition, one of the important decisions is to find the right doctors. We measure a doctor's expertise and clinical excellence by analyzing billions of data points about doctors worldwide. Our goal is to precisely and independently identify the right doctors that treat your conditions the best.

OxStem plans to develop small molecule drugs that can activate repair mechanisms that already exist within the body. Building on decades of experience in medicinal chemistry, OxStem will design drugs that can programme resident stem and stem-like cells in situ to treat currently untreatable age-related conditions.

Cypher Genomics, Inc. is a genome informatics company that specializes in automated human genome interpretation software solutions targeted at clinical labs, pharmaceutical companies, and population genomics initiatives. Founded in 2011 and based in La Jolla, California, the company's platform enables clinical laboratories to adjust sensitivity and specificity profiles for developing molecular tests for diagnostic and prognostic purposes. Additionally, it assists pharmaceutical firms in identifying biomarkers from whole genome sequence data, particularly in early-stage drug development studies. Cypher Genomics offers solutions such as Mantis, a software-as-a-service that provides clinical-grade summaries for genomic analyses, and Coral, a biomarker discovery service that integrates genome sequencing with clinical data to aid in therapy development. The company has established strategic partnerships with notable organizations in the field, including Celgene and Illumina. Cypher Genomics is now a subsidiary of Human Longevity, Inc.